Fact CheckerSign in

NCT05784766Active, not recruiting

Screening for Atrial Fibrillation in Patients With Cancer: A Pilot Randomized Controlled Clinical Trial

Source: ClinicalTrials.gov · Last updated 6 Apr 2026

Brief summary (registry, in English)

Patients with cancer have a higher incidence of AF but despite the higher incidence of AF in the cancer population, there are no randomized controlled trials (RCTs) for AF screening in this population. RCTs of AF screening in the general population have shown that screening can effectively detect AF earlier, and helps to identify candidates for appropriate anticoagulation that may lead to improvement in clinical outcomes.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
494 (actual)
First submitted
27 Feb 2023
Start date
6 Nov 2023
Primary completion date
13 Jun 2025
Lead sponsor
University of Oklahoma
NCT number
NCT05784766

What you commit to

  • Study type: Interventional
  • Participants enrolled: 494
  • From 6 Nov 2023 to the primary completion date, 13 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known history of atrial fibrillation.

Other

  • Non-English-speaking participants will not be enrolled

Who the study is looking for

  • Male and female patients age ≥65 with a current diagnosis or history of cancer.
  • Patients currently undergoing or history of chemotherapy, radiotherapy or cancer related surgeries will be included.
  • The age is restricted to ≥65 years because prevalence of AF is extremely low. .

Age in the registry: 65 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Oklahoma Health Sciences Center
Coordinator of this site? Confirm its status
Oklahoma CityUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.